Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesInterval to testosterone recovery after hormonal therapy for prostate cancer and risk of death
International Journal of Radiation Oncology*Biology*Physics, 09/01/09
D'Amico AV et al. – A longer TTR after RT plus 6 months of HT for unfavorable-risk PCa is associated with a lower risk of death in men with no or minimal comorbidity.
Methods- 206 men with localized, unfavorable risk PCa were randomized to RT or RT + 6 mos HT
- Of the 102 men randomized to receive RT and HT, 57 (56%) had a TTR of >2 years, and none of these men had died of PCa after a median follow-up of 7.6 years.
- As the TTR increased, the risk of death decreased significantly.
- The survival estimates were similar across the TTR values in men with moderate to severe comorbidity; however, these estimates increased significantly with decreasing PCa-specific mortality as the TTR increased in men with no or minimal comorbidity.
Related Articles
Safety and efficacy of testosterone gel in the treatment of male hypogonadism
Clinical Interventions in Aging, 10/12/09
Relevance Score: 48%
Testosterone and biological characteristics of breast cancers in postmenopausal women
Cancer Epidemiology, Biomarkers & Prevention, 10/28/09
Relevance Score: 47%
NIH-Supported Trial to Study Testosterone Therapy in Older Men
MedLinePlus, 11/04/09
Relevance Score: 46%
NIH-Supported Trial to Study Testosterone Therapy in Older Men
NIH, 11/03/09
Relevance Score: 46%
Testosterone supplementation: For whom and when?
Sexuality, Reproduction & Menopause, 10/08/09
Relevance Score: 46%
Today in Endocrine Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Neuroendocrine carcinomas arising in solid-organ transplant recipients: rare but aggressive malignancies
Oncology (Karger), 11/25/09
Malignant teratoma of the thyroid in a pregnant woman
Annals of Diagnostic Pathology, 11/23/09
Bevacizumab plus capecitabine as a salvage therapy in advanced adrenocortical carcinoma
European Journal of Endocrinology, 11/19/09
Today in Renal/Urologic...keeping you current
Receive free subspecialty "5-minute updates" via email
A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer
Cancer, 11/30/09
Inhibition of Akt signaling by the lignan matairesinol sensitizes prostate cancer cells to TRAIL-induced apoptosis
Oncogene, 11/30/09
Extrapulmonary small cell carcinoma in breast and prostate
Clinical and Translational Oncology, 11/30/09
Sponsor
Article Search
Sponsor
Sponsor